Abstract
In two recent Phase III clinical trials, use of a 25 mg dapivirine vaginal ring significantly reduced HIV acquisition rates. Post hoc analysis from one of the trials indicated higher rates of protection among women over the age of 21 years when compared to younger women, most likely due to reduced adherence in the latter group. There is currently no information available on how release of dapivirine from the ring is affected by either its intermittent removal from the vagina or women’s cleaning of the ring before re-insertion. Here, in vitro drug stability and product performance characteristics of the dapivirine ring were assessed under simulated conditions of real-world use. The impact of systematic deviations from the 28-day continuous use protocol upon in vitro release performance, was investigated. Also, the effect of ring exposure to a range of common household chemicals – including bath salts, bleach, detergent and personal lubricants – was examined through measurement of dapivirine content and stability. Dapivirine in vitro release under intermittent schedules was similar to that obtained under the normal continuous schedule ignoring the periods of interruption. Ring exposure to various household chemicals had no discernible impact on dapivirine assay value, degradation or stability.
Original language | English |
---|---|
Pages (from-to) | 351-357 |
Number of pages | 7 |
Journal | International Journal of Pharmaceutics |
Volume | 565 |
Early online date | 11 May 2019 |
DOIs | |
Publication status | Published - 30 Jun 2019 |
Keywords
- HIV microbicide
- Antiretroviral
- Silicone elastomer vaginal ring
- Intermittent use protocol
Fingerprint
Dive into the research topics of 'Drug stability and product performance characteristics of a dapivirine-releasing vaginal ring under simulated real-world conditions'. Together they form a unique fingerprint.Profiles
-
Peter Boyd
- School of Pharmacy - Senior Lecturer
- Material and Advanced Technologies for Healthcare
Person: Academic